Results 261 to 270 of about 34,214 (293)
Some of the next articles are maybe not open access.
Research progress on GPX4 targeted compounds
European Journal of Medicinal ChemistryBlocking the System Xc-_ GSH_GPX4 pathway to induce ferroptosis in tumor cells is a novel strategy for cancer treatment. GPX4 serves as the core of the System Xc-/GSH/GPX4 pathway and is a predominant target for inducing ferroptosis in tumor cells. This article summarizes compounds identified in current research that directly target the GPX4 protein ...
Bingru Li +8 more
openaire +2 more sources
Role of GPX4 in ferroptosis and its pharmacological implication
Free Radical Biology and Medicine, 2019Ferroptosis is a non-apoptotic form of cell death characterized by iron-dependent lipid peroxidation and metabolic constraints. Dependence on NADPH/H+, polyunsaturated fatty acid metabolism, and the mevalonate and glutaminolysis metabolic pathways have been implicated in this novel form of regulated necrotic cell death.
Seibt, T.M., Proneth, B., Conrad, M.
openaire +3 more sources
Targeting GPX4 palmitoylation to boost antitumor immunity
Trends in CancerDespite significant milestones in cancer immunotherapy, tumor cells often escape immune surveillance. Zhou et al. revealed that the pivotal ferroptosis suppressor glutathione peroxidase 4 (GPX4) can undergo palmitoylation by zDHHC8, enhancing ferroptosis resistance.
Daehee Hwang, Whitney S. Henry
openaire +2 more sources
An overview of GPX4-targeting TPDs for cancer therapy
Bioorganic & Medicinal ChemistryFerroptosis is a newly identified form of regulated, non-apoptotic cell death caused by iron-dependent phospholipid peroxidation. Glutathione peroxidase 4 (GPX4) inactivation-induced ferroptosis is an efficient antitumor treatment. Currently, several GPX4 inhibitors have been identified.
Xiaojuan, Yang +2 more
openaire +2 more sources
Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges
Trends in Pharmacological SciencesSelenoprotein glutathione peroxidase 4 (GPX4) serves as a crucial suppressor of oxidative stress-induced ferroptosis, making it an attractive target for disease therapy. Here, we discuss recent strategies and challenges associated with targeting GPX4 through covalent inhibitors, proteolysis targeting chimera (PROTAC) degraders, and cell-type-specific ...
Jiao Liu, Daolin Tang, Rui Kang
openaire +2 more sources
Lupus
Objectives: To investigate the association of serum glutathione peroxidase 4 (GPX4) levels and GPX4 polymorphisms with systemic lupus erythematosus (SLE) and lupus nephritis (LN) in a Chinese population. Methods: This hospital-based ...
Xu Li +11 more
openaire +1 more source
Objectives: To investigate the association of serum glutathione peroxidase 4 (GPX4) levels and GPX4 polymorphisms with systemic lupus erythematosus (SLE) and lupus nephritis (LN) in a Chinese population. Methods: This hospital-based ...
Xu Li +11 more
openaire +1 more source
Journal of Pharmacy and Pharmacology
Abstract Objectives Shuxuetong injection (SXT) treats cerebral ischemic injury by inhibiting apoptosis. However, the specific active ingredient responsible for this effect and its mechanism of action remain unclear.
Yujie Wu +9 more
openaire +2 more sources
Abstract Objectives Shuxuetong injection (SXT) treats cerebral ischemic injury by inhibiting apoptosis. However, the specific active ingredient responsible for this effect and its mechanism of action remain unclear.
Yujie Wu +9 more
openaire +2 more sources
Istraživanje feroptoznog inhibitora GPx4
2015Istraživanje feroptoznog inhibitora ...
openaire +1 more source

